deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT02735902

Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions (1:1) (AVATAR)

Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions - an Open, Multicenter Randomized Controlled Trial With Two Parallel Arms (1:1)

Sponsor: Centre Hospitalier Universitaire de Nīmes

Conditions Transcatheter Aortic Valve Replacement
Interventions Aspirin Vitamin K antagonist or direct oral anticoagulant treatment
Updated 14 times since 2017 Last updated: Jul 23, 2024 Started: Jun 1, 2017 Primary completion: Feb 2, 2023 Completion: Jan 19, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Transcatheter Aortic Valve Replacement, this trial is completed. The trial is conducted by Centre Hospitalier Universitaire de Nīmes and has accumulated 14 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Dec 2017 · 11 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshot~Mar 2019 – ~Oct 2019 · 7 months · monthly snapshot~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshot~Sep 2021 – ~Dec 2022 · 15 months · monthly snapshot~Dec 2022 – ~Oct 2023 · 10 months · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Aug 2024 — Sep 2024 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

  4. Jul 2024 — Aug 2024 [monthly]

    Recruiting PHASE4

  5. Oct 2023 — Jul 2024 [monthly]

    Recruiting PHASE4

▶ Show 9 earlier versions

  1. Dec 2022 — Oct 2023 [monthly]

    Recruiting PHASE4

  2. Sep 2021 — Dec 2022 [monthly]

    Recruiting PHASE4

  3. Feb 2021 — Sep 2021 [monthly]

    Recruiting PHASE4

  4. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE4

  5. Oct 2019 — Jan 2021 [monthly]

    Recruiting PHASE4

  6. Mar 2019 — Oct 2019 [monthly]

    Recruiting PHASE4

  7. Jun 2018 — Mar 2019 [monthly]

    Recruiting PHASE4

  8. Dec 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  9. Jan 2017 — Dec 2017 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Hospitalier Universitaire de Nīmes
  • Medtronic
Data source: Centre Hospitalier Universitaire de Nīmes

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations